Literature DB >> 25363356

Synthesis of PS/PO-chimeric oligonucleotides using mixed oxathiaphospholane and phosphoramidite chemistry.

Ewa Radzikowska1, Janina Baraniak.   

Abstract

Chimeric oligonucleotides containing phosphodiester and phosphorothioate linkages have been obtained using the solid phase synthesis. The oligonucleotide parts possessing natural internucleotide phosphate bonds were assembled using commercially available nucleoside 3'-O-(2-cyanoethyl-N,N-diisopropylamino)phosphoramidites 7 whereas the phosphorothioate segment was built using nucleoside 3'-O-(2-thio-1,3,2-oxathiaphospholanes) 3. The oxidation steps, crucial for the conversion of phosphite linkages into the phosphate moieties, were conducted using tert-butylperoxy-trimethylsilane, and this reagent was not harmful to the diester phosphorothioate linkages. When P-diastereopure nucleoside 3'-O-(2-thio-1,3,2-oxathiaphospholane) monomers were employed the resulting chimeric backbone retained the P-stereoregularity of the phosphorothioate units.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25363356     DOI: 10.1039/c4ob01837k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  A P(V) platform for oligonucleotide synthesis.

Authors:  Yazhong Huang; Kyle W Knouse; Shenjie Qiu; Wei Hao; Natalia M Padial; Julien C Vantourout; Bin Zheng; Stephen E Mercer; Javier Lopez-Ogalla; Rohan Narayan; Richard E Olson; Donna G Blackmond; Martin D Eastgate; Michael A Schmidt; Ivar M McDonald; Phil S Baran
Journal:  Science       Date:  2021-09-09       Impact factor: 63.714

2.  P-stereocontrolled synthesis of oligo(nucleoside N3'→O5' phosphoramidothioate)s - opportunities and limitations.

Authors:  Ewa Radzikowska; Renata Kaczmarek; Dariusz Korczyński; Agnieszka Krakowiak; Barbara Mikołajczyk; Janina Baraniak; Piotr Guga; Kraig A Wheeler; Tomasz Pawlak; Barbara Nawrot
Journal:  RSC Adv       Date:  2020-09-23       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.